Amanote Research
Register
Sign In
The Clinical Implications of Soluble PD-L1 in Hepatocellular Carcinoma Patients Treated With Radiation Therapy
International Journal of Radiation Oncology Biology Physics
- Netherlands
doi 10.1016/j.ijrobp.2017.06.214
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Date
October 1, 2017
Authors
H.J. Kim
S. Park
K.J. Kim
J. Seong
Publisher
Elsevier BV
Related search
Upregulation of Circulating PD-L1/PD-1 Is Associated With Poor Post-Cryoablation Prognosis in Patients With HBV-Related Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated With Checkpoint Blockade
Cancer immunology research
Cancer Research
Immunology
P1.13-32 Comparison Between Immune-Mediated Pneumonitis and Pneumonia in Patients Treated With PD-1/PD-L1 Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Soluble Forms of the Immune Check-Point Receptor PD-1 and Its Ligand PD-L1 in Blood Serum of Patients With Renal Cell Carcinoma: Clinical and Pathologic Correlations
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Significance of PD‑L1 Clones and C‑MET Expression in Hepatocellular Carcinoma
Oncology Letters
Cancer Research
Oncology
Stereotactic Body Radiation Therapy (SBRT) in Patients With Hepatocellular Carcinoma and Oligometastatic Liver Disease
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Clusterin Role in Hepatocellular Carcinoma Patients Treated With Oxaliplatin
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Radiation Therapy and Palliative Care Prolongs the Survival of Hepatocellular Carcinoma Patients With Bone Metastases
Internal Medicine
Internal Medicine
Medicine
Clinical Significance of Radiation-Induced Liver Disease After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Korean Journal of Internal Medicine
Internal Medicine
